adv editor Flashcards

1
Q

Lung volumes

TLC

VC

FVC

RV -

TV -

FRC

FEV1 -

FEV1/FVC -

A

TLC - total lung capacity - take a full breath in

VC - vital capacity - if you exhale all the way to the bottom of the lungs

FVC = forced vital capacity - exhale as forcefully as you can

total volume you can move

RV - residual volume = TLC - VC

TV - tidal volume - breathing normally

FRC - functional residual capacity = TLC-TV

FEV1 - the air that comes out in 1 second

usually all of FVC comes out in 3 seconds

FEV1/FVC - forced expiration ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the formula for maximum ventilation

how much do we need at rest?

A

MV = FEV1 * 35

at rest need roughly 8L/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the A-a gradient?

What is it a measure of?

What is the normal value, when do abnormalities occur

A

measure of gas exchange efficiency (takes a look at lung overall - how well O2 diffuses across)

A-a gradient = PAO2 - PaO2

PaO2 - measure

PAO2 estimate from ideal gas equation

Normal <15-30 (not 100% bc of shunts)

  • abnormality means Pa is much lower -> not diffusing across
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do you measure PAO2

A

This is the pressure in the Alveoli - need to estimate with idea gas equation

PAO2 = PiO2 - PACO2/RQ

PiO2 - mean inspired O2 (at sea level = 150)

PACO2 - can just sub in PaCO2 (very efficient)

RQ = 0.8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are normal values for PaCO2

What is normal for HCO3-

A

PaCO2 - 35-46mmHg

HCO3- 22-28mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Respiratory acidosis - what is it

Causes

Compensation

Signs

A

increase in CO2

decreased HCO3-CO2 ratio -> ↓pH

_Causes _

usually: ventilation issues - hypoventilation, or VQ mismatch

not perfusion (CO2 is usually ventillation-limited )

_Compensation _

kidneys preserve HCO3-

_Signs: _

↑CO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Metabolic acidosis

  • what is it
  • causes
  • compensation
  • signs
A

“metabolic” - primary change is in HCO3-

↓HCO3- relative to CO2 -> ↓pH

_Causes _

loss of HCO3- (eg diarrhoea)

buffering

accumulation of acids in blood - diabetes mellitus (ketoacid)

tissue hypoxia -> lactic acid

_Compensation _

increase in ventilation to ↓CO2

Signs:

↓ CO2

↓ HCO3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Respiratory alkalosis

  • what is it
  • causes
  • compensation
  • signs
A

decrease in PCO2 - this increases HCO3-PCO2 ratio => elevating pH

_Causes _

hyperventilation

high altitude

_Compensation _

kidneys increase excretion of HCO3-

_Signs _

↓ CO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metabolic alkalosis

  • what is it
  • causes
  • compensation
  • signs
A

increase in HCO3-

increases: HCO3-CO2 -> ↑pH

_Causes _

excessive ingestion of alkalis

loss of acid gastric secretion by vomiting

_Compensation _

some respiratory compensation - to reduce alveolar ventilation, thus increase CO2

often none

Signs:

↑HCO3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What % of total O2 use is normal WOB

A

3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the mechanical effects of airflow obstruction? (7)

A

Obstruction -> ↑friction in airways -> inspiratory muscles must generate higher negative P to overcome obstruction + expiration becomes active -> ↑restrictive WOB

  1. increased sensation of breathing
  2. increased respiratory muscle effort
  3. active exhalation
  4. prolonged inspiration + expiration (harder to exhale completely - ↓FEV1)
  5. altered pattern of breathing (↑restive WOB - long slow breaths)
  6. reduced maximum ventilation (↓FEV1 -> ↓FEV1*35)
  7. gas trapping
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is pulsus paradoxus?

A

normally during inspiration, systolic BP drops due to increased negative pressure in thorax - this pools blood in pulmonary system, and decreases CO -> decreases BP

then during expiration, systolic BP rises, as there are higher pressure in the thorax, pushing blood back to heart

normal variation in BP <10mmHg

pulsus paradoxus is >10mmHg (difference between systolic P at expiration and inspiration)

=> implies that there are greater negative pressures being produced during inspiration -> higher WOB

hard to use as clinical sign - hard to measure when someone agitated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Spirometry of obstructive airways disease?

A

Airflow obstruction - takes longer to get air in/out

↓FEV1 with the same FVC

FEV1/FVC <70% (forced exp ratio)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is normal maximum ventilation? What is that in regard to what you need at rest?

How does it change with exercise?

What limits exercise

A

MV > 100L/min

=>12x that of rest

max exercise - still have ~30% unused MV

Exercise is limited by max HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gas trapping - what is its link to obstructive airways

signs of gas trapping

A

Gas trapped beyond obstructed airways - can be inhaled, but not exhaled

signs

  • ↑TLC

↑RV

↑RV/TLC

decreases VC even though you are hyperinflated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Consequences of obstructed airways

A

Recruitment of accessory muscles (scalene, sternomastoid)

↑O2 consumption by respiratory muscles (can use 40-50% of O2)

risk of respiratory muscle fatigue -> limited window to treat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is V/Q matching?

When can V/Q mismatch occur

How does matching happen

What effect do V/Q mismatches have on PaO2

A

Gas exchange - most efficient when ventilation matches perfusion in all A-C units

V/Q mismatch if non-uniform airway osbtruction (asthma, COPD, bronchiolitis)

Matchin: Low V/Q units (those getting less ventilation than perfusion) result in ⌡PaO2

vasoconstriction occurs here to match

When V/Q = 0 => shunt (won’t respond to supplemental oxygen)

Low V/Q units - most clinically significant cause of ↓PaO2 in clinical practice

high V/Q units - little effect on PaO2, just physiological dead space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is most clinically significant cause of ↓PaO2 in clinical practice

A

V/Q mismatch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What effect may V/Q mistmatch have in extreme cases?

A

↑pulmonary artery pressure

  • vasoconstriction in low ventilation areas - if this is generalised (asthma), get generalised constriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Defining pathological features of restrictive lung diseases

A

inflammation and fibrosis of inter-alveolar septa (interstitium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Definition of compliance in the lungs

What components are important

A

Change in Volume for a change in pressure

Components:

  • tissue composition
  • surface tension in alveoli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what changes to tissue composition lead to reduced compliance

A

fibrotic, inflammatory, malignant, infective processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the gas exchange effects of restrictive lung disease?

What are the mechanical effects

A

Gas exhange:

  1. Abnormal exchange - worsens with exercise

Mechanical

  1. increased sensation of breathing
  2. increased elastic WOB
  3. reduced lung volumes
  4. altered pattern of breathing
  5. reduced maximum ventilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what are the physiological efects of a disruption to the AC membrane?

A

Abnormal gas exchange

Abnormal lung mechanics

Pulmonary vascular complications, if enough of pulm bed is affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what happens to gas exchange in restrictive lung disease, and why (O2 and CO2)

A

Diffusion - need integrity of AC membrane (thickness, surface area)

Get a diffusion limitation of O2 transfer (usually is limited by ventilation) (the graph where blood stays in capillar .25 or .75 secs)

Diffusion limitation for CO2 will occur with very severe abnormalities of AC membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Potential causes of

  • low PaO2
  • low PaCO2
A

low PaO2

  • low inspired O2
  • low ventilation
  • abnormal gas exchange (low V/Q, shunt, diffusion impairment)

low PaCO2

  • low ventilation

(abnormal exchange only in VERY severe disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

why does restrive lung disease increase sensation of breathing? (breathlessness)

A

stiff lungs - increase elastic WOB - increase load on breathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what happens to lung volumes in respiratory lung disease?

A

all lung volumes reduced

both ↓FEV1 and FVC => ratio stays constant

(can have both restrictive + obstructive => ↓FEV1/FVC + ↓FVC)

29
Q

what pattern of breathing is seen in restrictive lung disease?

A

high frequency - rapid, shallow breaths

30
Q

what happens to max ventilation in restrictive lung disease? why?

A

MV = 35 * FEV1

FEV1↓ so ↓MV

31
Q

spirometry in restrictive lung disease

A

all lung volumes are reduced

↓FVC

↓FEV1

normal FEV1/FVC

32
Q

what is asbestosis?

what type of lung disease

pathophysiology

histology

presentation

A

diffuse interstitial lung disease due to exposure to asbestos => restrictive

pathophys

  • progressive, diffuse inflammation -> over time drives fibrosis > repair
  • abnormal fibrosis of lung parenchyma -> disruption/destruction of AC membrane

histo

  • areas of inflammation
  • fibrosis/scarring
  • asbestos bodies

presentation = 3C’s (clubbing, cyanosis, crepitations)

33
Q

What is idiopathic pulmonary fibrosis?

type of lung disease

cause

histology

prognosis

A

restrictive lung disease (interstitial)

cause: unknown

histo

  • interstitial inflammation
  • fibrosis at various stages of development

prognosis

  • inevitable progression to end-stage lung
  • mean survival - 3 years
34
Q

What normally happens to fluid in the lung?

How/why can oedema form

A

Normall - small amount of fluid leaks from capillary to interstitium (~5ml an hour)

(capillary endothelium is highly permeable to water, ions, small molecules)

=> this is drained by lymphaticflow (~20ml/hr)

if fluid leak >20ml/hr => oedema

  • fluid accumulate in interstitium, then moves to alveoli
35
Q

are alveoli normally wet or dry?

A

dry - epithelium actively pumps water back to intersitium

36
Q

What are the 2 mechanisms that cause pulmonary oedema?

What are the 2 other mechanisms that theoretically could cause it

A

(1) increased capillary hydrostatic pressure (Starling’s law)
- increased pulmonary venous pressure, left heart pressure
(2) Increased capillary permeability
- toxins, sepsis, multiple trauma, aspiration of gastric acid etc.

Theoretically: ↓colloid osmotic pressure, ↓lymp drainage

= but these aggravate, not cause

37
Q

signs of pulmonary oedema (CXR)

A

CXR

  • Kerley B lines
    • dilated interlobular septa
    • dilated lymphatics
  • Perihilar alveolar opacities
    • ↑pulmonary vein size
38
Q

Consequences of fluid in the lungs (4)

A

Mechanical changes - small, stiff lungs

Gas exhange abnormality - low V/Q units + shunt

Pulmonary circulation - ↓vascular resistance

Arterial blood gasses - type 1 resp initiall, then develop type 2

39
Q

What mechanical changes are seen as a result of pulm oedema?

A

↓compliance,

↓lung vol,

↑airway resistance -fluid in airway, bronchioles are compressed,

↑wob

40
Q

What changes in blood gasses are seen in pulmonary oedema?

A

type 1 respiratory failure initially

  • ↓ PaO2
  • ↓ PaCO2
    • compensatory hyperventilation
  • ↑ pH
    • respiratory alkalosis - because of hyperventilation

then develop type 2 respiratory failure

  • ↓ PaO2
  • ↑ PaCO2
  • ↓pH
    • metabolic and respiratory acidosis
    • metabolic: becaues of hypoxia - tissues start to produce lactic acid
    • respiratory: can’t ventilate -> ↑CO2
41
Q

Causes of pulmonary hypertension (broad) (3)

A

(1) Increased left atrium pressure (mitral stenosis, LVF)
(2) Increased pulmonary blood flow (left-to-right shunts, high flow states, excess central vol)
(3) Increased pulmonary vascular resistance (vasoconstriction, obstruction, obliteration)

42
Q

What can cause increased pulmonary vascular resistance?

A

Vasoconstriction - low alveolar O2, hypoxia, muscle spasm

Obstruction - emobolism, primary pulmonary hypertension

Obliteration = loss of capillary bed

(interstitial lung disease - arteritis, emphysema, pulmonary fibrosis)

43
Q

Consequences of pulmonary hypertension

A

if very severe - right ventricular dilatation + hypertrophy (afterload)

=> ↑systemic venous pressure (extravasation of fluid in tissues) - oedema, ascities

=> poor cardiac output (breathlessness)

44
Q

Clinical signs of pulmonary hypertension

A
  • right ventricular heave - feel beat of RV (just next to sternum)
  • loud P2 and 4th heart sound
  • pulmonary systolic ejection murmur
    • right heart is dilated - cusps can’t come together, don’t have functional tricuspid anymore
    • tricuspid pansystolic murmur -> incompetence
  • sinus tachycardia - get decreased SV, so have to increase rate
  • hepatomegaly
  • ascites
45
Q

how does smoking predispose to pulmonary infection?

A
  • inhibits muco-ciliary escalator
  • increases mucous (direct trigger)
  • inhibits leukocyte function
  • direct damage to epithelial layer
46
Q

causes of hypoventilation (5)

A
  • **Reduced respiratory centre activity **
    • reduced drive (eg low CO2, high pH)
    • suppression of activity (drugs, trauma, vascular accidents etc )
  • **Neuromuscular disease **
    • nerve paralysis (drugs, polio, Guillian-Barre, trauma..)
    • muscle weakness (drugs, motor neurone disease, muscular dystrophy )
  • Chest wall deformity (gross)
    • respiratory pump becomes inefficient
  • Obesity (gross)
    • respiratory pump becomes inefficient
  • **Sleep disordered breathing **
47
Q

what are the types of sleep disordered breathing? Where is the abnormality

A

(1) Obstructive sleep apnoea - most common
* upper airway
(2) Central sleep apnoea

  • main abnormality: brain stem
  • several forms: eg Cheye Stokes breathing - delayed stimulus to brainstem
  • management: manage underlying problem +/- CPAP/BiPAP

(3) Obesity hypoventilation syndrome

  • combo: particularly diaphragm
  • usually presents as ventilatory failure +/- RHF
  • “sensitive” to supplemental O2
  • manage: BiPAP, weight reduction
48
Q

What are the consequences of chronic severe sleep apnoea

A

Must sleep

During sleep - you get hypoventilation (resetting of resp centre)

-

patient keeps waking due to inadequate stimulation (↓O2, ↑CO2)

brain “decides” that LR sleep deprivation is not tenable -> brain starts to accept a higher C O2 and lower O2 so that sleep can continue

this spills over into daytime -> day-time hypoventilation => hypercapnoea

49
Q

what conditions cause day time hypoventilation

what are its consequences

A

day time hypoventilation (chronic severe sleep apnoea, severe COPD, severe pulm fibrosis, neuromusc disease)

=> chronic hypoxia, chronic hypercapnoea, compensated resp acidosis

50
Q

chronic hypercapnoea - what controls ventilation

A

become dependent on hypoxic drive (not stimulated to ventilate by CO2)

  • O2 is low because of chronic hypoventiliation

ventilation also stimulated by exercise, metabolic acidosis

51
Q

why must you be careful when givin supplemental oxygen?

A

If someone has had chronic hypercapnoea - their drive to breathe will have swtiched from CO2 to O2

=> supplemental O2 brings PaO2 back up - can develop acute hypoventilation

only give enough O2 to bring them back to “their normal” - ~90-ish

don’t aim for 100 ish - then will dev acute hypoventilation

52
Q

What is teh cycle of events in obstructive sleep apnoea

A
  1. Snoring in light sleep
  2. Complete obstruction (apnoea) in deep sleep
    1. some people have narrowing such that this occurs with light sleep
  3. Reduced blood O2, increased CO2 other stimuli
    1. trying to breathe against obstruction
    2. increasingly forceful breaths - icn WOB is another stimulus
  4. Brain “wakes” to lighter sleep (arousal)
    1. this takes some compared to while awake - sensing by brain is also depressed during sleep
  5. Muscles contract, airways opens, breathing recommences
    1. muscles regain tone, obstruction clears (at least partially)
  6. Back into deep sleep -> obstruct again

Often 60x per hour throughout sleep

53
Q

management of obstructive sleep apnoea

A
  • Nasal CPAP - continuous positive airway pressure
    • applies positive pressure to upper airway during sleep
    • pressure acts as splint to keep soft tissues apart - stops their collapse
    • 85% compliance for moderate+ OSA
  • Mandibular advancement splint - mouthguard
    • brings jaw forward, base of tongue brought bwd, tends to stop it flopping back
  • Surgery
  • Lie on side
54
Q

what is obstructive sleep apnoea?

Why does it occur?

A

Transient obstruction of the throat during sleep preventing breathing, and disturbing sleep

Obstruction occurs during sleep because of

  • relaxed airway muscles - floppy throat (esp REM)
  • throat already arrowed (obesity, tonsils etc)
  • tongue falls backward (esp if supine)
55
Q

Pathophys of Pulmonary embolism

A

Thromboembolus lodges in pulmonary circulation

Effects depend on: size of embolus, presence/absence of underlying lung and cardiovascular disease

Embolus leads to development of:

  • hypoxaemia
  • local pulmonary artery obstruction + widespread reflex vasoconstriction
    • increases pressure in system
      • RV stress -> dilation and contractile dysfunction
    • platelets in thrombi can release TXa -> lead to vasoconstriction
  • Constriction of airways distal to bronchi
  • decreased pulmonary compliance
    • haemorrhage, loss of surfactant
    • VQ mismatch -> acute pulmonary hypertension
56
Q

Consequences of PE

A

Depends on the size

Large/numerous

  • if >60% of vascular bed is occluded - sudden collapse + death
  • acute cor pulmonale - dyspnoea, hypotension (↓LV output), cyanosis
    • pulmonary hypertension in setting of underlying lung problem

Medium sized

  • Dyspnoea, cough, acute cor pulmonale
  • Pulmonary infarction (relatively uncommon - blood supply of lung )

Small sized

  • may be clinically silent
  • pulmonary infarction
  • recurrent
    • many small emboli over time -> chronic pulmonary hypertension + cor pulmonale
57
Q

Pulmonary infarct

  • lung blood supply
  • why are infarcts rare, what makes them more likely
  • path morphology
  • signs
A

rare - dual blood supply:

  • O2 comes in via bronchial arteries and pulmonary arteries (even though deox blood)

more common if there is pre-existing lung and/or cardiovascular disease (eg heart failure - bronchial supply is sluggish; COPD - already hypoxaemic)

typically seen as peripheral, wedge-shaped, haemorrhagic

tissue dies because there is not enough O2, but there is still blood there -> red infarct

Signs

  • haemoptysis
  • pleuritic chest pain (acute inflammation -> fibrous exudate -> chest pain)
  • pleural friction run (from associated inflammation)
  • pleural effusion (because of inflammation)
58
Q

Where do you get a saddle embolus?

A

Pulmonary trunk + both R&L pulm arteries

59
Q

Pulmonary infarct - histology

A

Early

  • coagulative necrosis + inflammation

Heals same as MI - acute inflammation, granulation tissue, fibrosis + scar formation

60
Q

Pathogenesis of lung cancer

what is the dysplasia-carcinoma sequence

A
  • Smoke irritant -> epithelium undergoes squamous metaplasia
    • stem cells -> stratified squamous cells instead of respiratory epithelium
  • Carcinogens in smoke cause mutations in proto-oncogees and tumour suppressor genes -> **dysplasia **
    • get increased nuclei at surface compared to normal squamous epithelium
      • bit more disorganised
  • carcinoma in situ - more atypical and disorganised
  • these cells invade into underlying stroma -> **invasive carcinoma **
61
Q

Morphology of lung cancer (path)

A

Typically:

  • pale mass, irregular, often arising from bronchus
  • often necrotic (left) - form cavities
    • especially squamous cell carcinoma
  • adeno: tend to be more peripheral
  • enlarged hilar lymph nodes
62
Q

What are consequences of blocked bronchi (lung cancer)

A

if bronchus is blocked -> can develop

  • pneumonia - mucus is obstructed - good place for bacteria to grow
  • collapse or bronchiectasis of distal lung
63
Q

What are the lung cancer classifications?

A

Squamous cell carcinoma => squamous proliferation

Adenocarcinoma => glandular stem cells

Large cell undiff => undiff cells, but of epithelial type (ep’m proteins)

Small cell carcinoma => neuroendocrine origin

64
Q

Squamous cell carcinoma histology

A

normally seen in the form of rounded centre of keratin in centre of tumour islands

joined by intercellular bridges

often a lot of eosinophilic cytoplasm (squamous cells - lots of cytoplasm)

65
Q

Adenocarcinoma of lung histology

A

shows glandular differentiation

usual feature: malignant cells that try to form a lumen

sometimes no cells - see accumulation of mucous (with special stain)

66
Q

large cell undifferentiated carcinoma of the lung - histology

A

lots of large cells

large pleomorphic nuclei - usually sheets of these larger atypical cells

undifferentiated - no glands, mucous, intercellular bridges, keratin

67
Q

small cell carcinoma of the lung - histology

A

cells are small - not that big compared to RBC

don’t show typical features of malignancy

  • small
  • small nuclei
  • not that pleomorphic
  • fine chromatin

but have a “characteristic look”

68
Q

Whatis the most common lung cancer?

Which ones are strongly associated wtih smoking?

A

Adenocarcinoma

Smokers: squamous, small-cell, large-cell

69
Q

Targeted treatment for lung adenocarcinoma

A

Mutations in adenocarcinoma: EGFR (tyrosine kinase), ALK, K-RAS, B-RAF

Gefitinim, Erlotinib - inhibit EGFR tyrosine kinase

(different mutations in diff tumors - have to genotype)